BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31745967)

  • 21. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer.
    Nagata T; Shimada Y; Sekine S; Moriyama M; Hashimoto I; Matsui K; Okumura T; Hori T; Imura J; Tsukada K
    Breast Cancer; 2017 Mar; 24(2):326-335. PubMed ID: 27300169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival.
    Tozbikian G; Brogi E; Kadota K; Catalano J; Akram M; Patil S; Ho AY; Reis-Filho JS; Weigelt B; Norton L; Adusumilli PS; Wen HY
    PLoS One; 2014; 9(12):e114900. PubMed ID: 25506917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer.
    Li X; Song C; Wang K; Li N; Sun S; Li N; Zhao Z; Li M
    Cancer Biomark; 2019; 25(1):19-27. PubMed ID: 31033460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
    Lee HJ; Kim JY; Song IH; Park IA; Yu JH; Gong G
    Oncology; 2015; 89(6):337-44. PubMed ID: 26413775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer].
    Tan L; Qin H; Piao Y; Liu Z; Han Y; Song F; Xie X
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):827-32. PubMed ID: 26887512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.
    Matsuo K; Gray MJ; Yang DY; Srivastava SA; Tripathi PB; Sonoda LA; Yoo EJ; Dubeau L; Lee AS; Lin YG
    Gynecol Oncol; 2013 Mar; 128(3):552-9. PubMed ID: 23200913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays.
    Fan L; Sui XY; Jin X; Zhang WJ; Zhou P; Shao ZM
    BMC Cancer; 2023 Apr; 23(1):298. PubMed ID: 37005579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
    Yan J; Wang R; Wu Z
    J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of neuroendocrine markers predicts increased survival in triple-negative breast cancer patients.
    Xia C; Shen S; Pang J; Chen L; Yan J; Liang Z; Ren X
    Front Endocrinol (Lausanne); 2023; 14():1205631. PubMed ID: 38125789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
    Maierthaler M; Kriegsmann M; Peng C; Jauch S; Szabo A; Wallwiener M; Rom J; Sohn C; Schneeweiss A; Sinn HP; Yang R; Burwinkel B
    Exp Mol Pathol; 2015 Aug; 99(1):180-7. PubMed ID: 26112095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.
    Zheng H; Li X; Chen C; Chen J; Sun J; Sun S; Jin L; Li J; Sun S; Wu X
    Int J Nanomedicine; 2016; 11():5519-5529. PubMed ID: 27799773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
    M-Rabet M; Cabaud O; Josselin E; Finetti P; Castellano R; Farina A; Agavnian-Couquiaud E; Saviane G; Collette Y; Viens P; Gonçalves A; Ginestier C; Charafe-Jauffret E; Birnbaum D; Olive D; Bertucci F; Lopez M
    Ann Oncol; 2017 Apr; 28(4):769-776. PubMed ID: 27998973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes.
    Elfgen C; Reeve K; Moskovszky L; Güth U; Bjelic-Radisic V; Fleisch M; Tausch C; Varga Z
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2051-2059. PubMed ID: 31270600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
    Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.